MilliporeSigma Awarded Second U.S. Patent for CRISPR Gene-Editing Technology
Go back to MilliporeSigma Awarded Second U.S. Patent for CRISPR Gene-Editing Technology| (AMEX: MKKGY) | Delayed: 32.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.25 | 52 Week High | $ | |||
| Open | $32.25 | 52 Week Low | $ | |||
| Day High | $32.25 | P/E | N/A | |||
| Day Low | $32.25 | EPS | $ | |||
| Volume | 3,902 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 141.82 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $141.82 | 52 Week High | $65.46 | |||
| Open | $141.82 | 52 Week Low | $47.97 | |||
| Day High | $141.82 | P/E | 96.48 | |||
| Day Low | $141.82 | EPS | $1.47 | |||
| Volume | 5,793 | |||||



